Trial intelligence / Profile preview

Diquafosol vs Hyaluronate for Dry Eye After Cataract Surgery

NCT02608489Completed

Sponsor
Soonchunhyang University Hospital
Start
Jan 2014
Primary completion
Jan 2015
Modality
Small Molecules
01

Overview

Randomised, open-label trial of diquafosol in dry eye syndrome (DED) (2 arms), sponsored by Soonchunhyang University Hospital. Primary endpoints: Ocular Surface Disease Index at 12 weeks, Schirmer I Test Without Anesthesia at 12 weeks and 4 more. Started Jan 2014; status: completed.

02

Drugs

diquafosol
03

Conditions

dry eye syndrome (DED)

Beyond the preview

Go deeper on NCT02608489.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02608489.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call